1. Shankar, R, Perera, B, Thomas, RH. Epilepsy, an orphan disorder within the neurodevelopmental family. J Neurol Neurosurg Psychiatry 2020; 91: 1245–1247.
Google Scholar | Crossref | Medline2. Royal College of Psychiatrists . Prescribing anti-epileptic drugs for people with epilepsy and intellectual disability (CR206 Oct 2017), https://www.rcpsych.ac.uk/improving-care/campaigning-for-better-mental-health-policy/college-reports/2017-college-reports/prescribing-anti-epileptic-drugs-for-people-with-epilepsy-and-intellectual-disability-cr206-oct-2017 (2017, accessed 10 February 2021).
Google Scholar3. Chapman, M, Iddon, P, Atkinson, K, et al. The misdiagnosis of epilepsy in people with intellectual disabilities: a systematic review. Seizure 2011; 20: 101–106.
Google Scholar | Crossref | Medline4. Royal College of Psychiatrists. Management of epilepsy in adults with intellectual disability. Good Psychiatric Practice CR203: College Report, https://www.rcpsych.ac.uk/docs/default-source/improving-care/better-mh-policy/college-reports/college-report-cr203.pdf?sfvrsn=c534ff08_2 (2017, accessed 10 February 2021).
Google Scholar5. Aldenkamp, AP. Effect of seizures and epileptiform discharges on cognitive function. Epilepsia 1997; 38(Suppl. 1): S52–S55.
Google Scholar | Crossref | Medline6. Kiani, R, Tyrer, F, Jesu, A, et al. Mortality from Sudden Unexpected Death in Epilepsy (SUDEP) in a cohort of adults with intellectual disability. Intellect Disabil Res 2014; 58: 508–520.
Google Scholar | Crossref | Medline7. Devinsky, O, Hesdorffer, DC, Thurman, DJ, et al. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol 2016; 15: 1075–1088.
Google Scholar | Crossref | Medline8. Hesdorffer, DC, Tomson, T, Benn, E, et al. Combined analysis of risk factors for SUDEP. Epilepsia 2011; 52: 1150–1159.
Google Scholar | Crossref | Medline | ISI9. Young, C, Shankar, R, Palmer, J, et al. Does intellectual disability increase sudden unexpected death in epilepsy (SUDEP) risk? Seizure 2015; 25: 112–116.
Google Scholar | Crossref | Medline10. Doran, Z, Shankar, R, Keezer, M, et al. Managing anti-epileptic drug treatment in adult patients with intellectual disability: a serious conundrum. Eur J Neurol 2016; 23: 1152–1157.
Google Scholar | Crossref | Medline11. Jackson, CF, Makin, SM, Marson, AG, et al. Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database Syst Rev 2015; 9: CD005399.
Google Scholar12. Kerr, MP, Mensah, S, Besag, F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52: 2133–2138.
Google Scholar | Crossref | Medline | ISI13. Amiet, C, Gourfinkel-An, I, Bouzamondo, A, et al. Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry 2008; 64: 577–582.
Google Scholar | Crossref | Medline | ISI14. Gillham, R, Baker, G, Thompson, P, et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996; 24: 47–55.
Google Scholar | Crossref | Medline15. Javed, A, Cohen, B, Detyniecki, K, et al. Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: an extended follow-up. Seizure 2015; 29: 34–40.
Google Scholar | Crossref | Medline16. Wojewodka, G, McKinlay, A, Ridsdale, L. Best care for older people with epilepsy: a scoping review. Seizure 2021; 85: 70–89.
Google Scholar | Crossref | Medline17. Bhaumik, S, Gangadharan, SK, Branford, D et al. The Frith prescribing guidelines for people with intellectual disability. Chichester, England: Wiley Blackwell, 2015.
Google Scholar | Crossref18. Hermans, H, Evenhuis, HM. Multimorbidity in older adults with intellectual disabilities. Res Dev Disabil 2014; 35: 776–783.
Google Scholar | Crossref | Medline | ISI19. McCarron, M, Swinburne, J, Burke, E, et al. Patterns of multimorbidity in an older population of persons with an intellectual disability: results from the intellectual disability supplement to the Irish longitudinal study on aging (IDS-TILDA). Res Dev Disabil 2013; 34: 521–527.
Google Scholar | Crossref | Medline | ISI20. Perucca, E, Berlowitz, D, Birnbaum, A, et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 2006; 68: 49–63.
Google Scholar | Crossref | Medline | ISI21. O’Dwyer, M, Peklar, J, Mulryan, N, et al. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities. J Intellect Disabil Res 2018; 62: 245–261.
Google Scholar | Crossref | Medline22. O’Dwyer, M, Maidment, ID, Bennett, K, et al. Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study. Br J Psychiatry 2016; 209: 504–510.
Google Scholar | Crossref | Medline23. Hilmer, SN, Mager, DE, Simonsick, EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167: 781–787.
Google Scholar | Crossref | Medline24. Ruxton, K, Woodman, RJ, Mangoni, AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol 2015; 80: 209–220.
Google Scholar | Crossref | Medline25. Schmitz, B. Effects of antiepileptic drugs on mood and behavior. Epilepsia 2006; 47: 28–33.
Google Scholar | Crossref | Medline26. Nadkarni, S, Devinsky, O. Psychotropic effects of antiepileptic drugs. Epilepsy Curr 2005; 5: 176–181.
Google Scholar | SAGE Journals27. Deb, S, Brizard, BA, Limbu, B. Association between epilepsy and challenging behaviour in adults with intellectual disabilities: systematic review and meta-analysis. BJPsych Open 2020; 6: e114.
Google Scholar | Crossref | Medline28. Frighi, V, Morovat, A, Stephenson, MT, et al. Vitamin D deficiency in patients with intellectual disabilities: prevalence, risk factors and management strategies. Br J Psychiatry 2014; 205: 458–464.
Google Scholar | Crossref | Medline | ISI29. Cock, HR. Bone health in epilepsy, Chapter 40. London: Epilepsy Group, 2021.
Google Scholar30. Frighi, V, Morovat, A, Andrews, TM, et al. Vitamin D, bone mineral density and risk of fracture in people with intellectual disabilities. J Intellect Disabil Res 2019; 63: 357–367.
Google Scholar | Crossref | Medline31. Sheehan, R, Hassiotis, A, Walters, K, et al. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. BMJ 2015; 351: h4326.
Google Scholar | Crossref | Medline32. Burke, É, Carroll, R, O’Dwyer, M, et al. Quantitative examination of the bone health status of older adults with intellectual and developmental disability in Ireland: a cross-sectional nationwide study. BMJ Open 2019; 9: e026939.
Google Scholar | Crossref | Medline33. Watkins, L, O’Dwyer, M, Shankar, R. New anti-seizure medication for elderly epileptic patients. Expert Opin Pharmacother 2019; 20: 1601–1608.
Google Scholar | Crossref | Medline34. Taylor, DM, Barnes, TR, Young, AH. The Maudsley prescribing guidelines in psychiatry. Hoboken, NJ: John Wiley & Sons, 2018.
Google Scholar35. Allard, J, Henley, W, Snoeijen-Schouwenaars, F, et al. European perspective of perampanel response in people with intellectual disability. Acta Neurol Scand 2020; 142: 255–259.
Google Scholar | Crossref | Medline36. Allard, J, Lawthom, C, Henley, W, et al. Eslicarbazepine acetate response in intellectual disability population versus general population. Acta Neurol Scand. Epub ahead of print 24 November 2020. DOI: 10.1111/ane.13368.
Google Scholar | Crossref37. Allard, J, Henley, W, Mclean, B, et al. Lacosamide in the general population and in people with intellectual disability: similar responses? Seizure 2020; 76: 161–166.
Google Scholar | Crossref | Medline38. Shankar, R, Henley, W, Wehner, T, et al. Perampanel in the general population and in people with intellectual disability: differing responses. Seizure 2017; 49: 30–35.
Google Scholar | Crossref | Medline39. Branford, D, Gerrard, D, Saleem, N, et al. Stopping over-medication of people with intellectual disability, autism or both (STOMP) in England part 1–history and background of STOMP. Adv Ment Health Intellect Disabil 2019; 13: 31–40.
Google Scholar | Crossref40. Robertson, J, Chadwick, D, Baines, S, et al. Prevalence of dysphagia in people with intellectual disability: a systematic review. Intellect Dev Disabil 2017; 55: 377–391.
Google Scholar | Crossref | Medline41. McCarron, M, McCallion, P, Reilly, E, et al. A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome. J Intellect Disabil Res 2017; 61: 843–852.
Google Scholar | Crossref | Medline42. Shankar, R, Wilcock, M. Improving knowledge of psychotropic prescribing in people with intellectual disability in primary care. PLoS One 2018; 13: e0204178.
Google Scholar | Crossref | Medline43. Shankar, R, Mitchell, S. Step together. Integrating care for people with epilepsy and a learning disability. Birmingham: BILD, 2020.
Google Scholar